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ABSTRACT
Regulation of endogenous genes by DNA-binding
polyamides requires effective nuclear localization.
Previous work employing confocal microscopy to
study uptake of fluorophore-labeled polyamides has
demonstrated the difficulty of predicting a priori the
nuclear uptake of a given polyamide. The data
suggest that dye identity influences uptake suffi-
ciently such that a dye-conjugate cannot be used as
a proxy for unlabeled analogs. Polyamides capable
of nuclear localization unaided by fluorescent dyes
are desirable due to size and other limitations of
fluorophores. Recently, a polyamide-fluorescein
conjugate targeted to the hypoxia response element
(HRE) was found to inhibit vascular endothelial
growth factor (VEGF) expression in cultured HeLa
cells. The current study uses inhibition of VEGF
expression as a biological read-out for effective
nuclear localization of HRE-targeted polyamides.
We synthesized a focused library of non-fluorescent,
HRE-targeted polyamides in which the C-terminus
‘tail’ has been systematically varied. Members of this
library bind the HRE with affinities comparable or
superior to that of the fluorescein-labeled analog.
Although most library members demonstrate modest
or no biological activity, two non-fluorescent poly-
amides are reported with activity rivaling that of the
previously reported fluorescein-labeled polyamide.
We also show evidence that promoter occupancy by
HIF-1, the transcription factor that binds the HRE, is
inhibited by HRE-targeted polyamides.
INTRODUCTION
Polyamides containing N-methylimidazole (Im) and N-
methylpyrrole (Py) comprise a class of programmable
DNA-binding ligands capable of binding to a broad repertoire
of DNA sequences with affinities and specificities compara-
ble to those of natural DNA-binding proteins (1,2). Sequence
specificity is programmed by side-by-side pairings of the
heterocyclic amino acids in the minor groove of DNA: Im/
Py distinguishes GC from CG; Py/Py binds both AT and
TA; and 3-chlorothiophene/N-methylpyrrole (Ct/Py) prefers
TA over AT at the N-terminus position (3–5). The use of
polyamides to modulate the expression of selected genes
through interaction with transcriptional machinery could
have applications in biology and human medicine (1,2).
Regulation of endogenous genes by DNA-binding small
molecules requires cellular uptake and nuclear localization
(6–9), chromatin accessibility (10,11) and site-specific inter-
actions with gene promoters sufficient to interfere with spe-
cific transcription factor–DNA interfaces (12–15).
The use of confocal microscopy to visualize subcellular
localization of fluorophore-labeled molecules is a convenient
method to study uptake and trafficking of polyamides in
living cells (6–9). Nuclear localization of more than 100
hairpin polyamide-fluorophore conjugates in several human
cell lines has been examined using this method (8,9). Py/Im
content, number and location of positive and negative charges,
presence of a b-alanine residue at the C-terminus, choice
of fluorophore, linker composition and attachment point have
been shown to influence nuclear localization of polyamide-
fluorophore conjugates (8,9). Although a significant number
of eight-ring hairpin-polyamides with fluorescein at the
C-terminus were shown to have good nuclear uptake in 10 cell
lines, this complexity makes it difficult to predict a priori the
subcellular distribution of a particular polyamide-fluorophore
conjugate. Efficient nuclear localization of a fluorophore
conjugate is not necessarily predictive for non-fluorescent
analogs. Screening polyamides for a biological effect depen-
dent on nuclear localization is a viable approach for the assess-
ment of nuclear uptake and does not require incorporation of
an optical tag. As polyamides are studied in model systems
of greater biological complexity, molecules that can access
the nuclei of cells without the use of fluorescent dyes are
desirable.
Polyamide-fluorescein conjugate 1 (Figure 1) was designed
to bind the sequence 50-ATACGT-30 within the hypoxia
response element (HRE) in the vascular endothelial growth
factor (VEGF) enhancer. It was found to bind its target site
with an affinity of 6.3 · 109 M1, disrupt hypoxia-inducible
factor 1 (HIF-1) binding to the HRE in vitro, enter the nuclei
of HeLa cells, and inhibit hypoxia-induced VEGF mRNA and
protein production in cultured HeLa cells (Figure 2A–C) (16).
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A control polyamide 2 designed to bind the DNA sequence
50-WGGWCW-30 (where W denotes an A or T) also exhibited
nuclear localization, but had a modest effect on VEGF
expression. Independently, the DNA-binding antibiotic echi-
nomycin, which binds 50-ACGT-30, was found to inhibit
VEGF expression in U251 cells (17,18). The finding that
two molecules of different structure bind the same HRE
sequence 50-TACGT-30 and exhibit similar biological effects
on hypoxia-driven gene expression validates the concept
of using small molecules to interfere with protein–DNA
interfaces.
The current study utilizes the inhibition of hypoxia-
induced VEGF expression as a biological read-out for nuclear
localization of polyamides targeted to the HRE. As a control,
we show that a polyamide-fluorescein conjugate 3 that targets
the HRE but exhibits poor nuclear localization in HeLa cells
due to a non-optimal linker (8) has a limited effect on
hypoxia-induced VEGF expression. We have synthesized a
focused library of polyamides with an identical core sequence
Figure 1. Structures of polyamide-fluorescein conjugates 1–3. Polyamides
1 and 3 target the sequence 50-WTWCGW-30, while polyamide 2 targets
the sequence 50-WGGWCW-30. Polyamide 3 differs from 1 and 2 in the
linker region between the polyamide core sequence and the fluorescein
moiety. Open circles designate N-methylpyrrole, closed circles designate
N-methylimidazole, squares designate 3-chlorothiophene and diamonds
designate b-alanine.
Figure 2. (A) Schematic illustration of polyamide 1 binding to the VEGF
HRE. (B) Uptake of polyamides 1–3 in HeLa cells. Polyamides 1 (left) and 2
(center) localize in the nucleus while polyamide 3 (right) localizes in the
nucleus to a limited extent but is largely extracellular. (C) Induction of VEGF
mRNA by the hypoxia mimetic deferoxamine (DFO) in the presence of
polyamides 1–3 measured by quantitative real-time PCR. Polyamide 1
inhibits the expression of DFO-induced VEGF expression. Polyamides 2 and
3 have a more modest effect. (D) Chromatin immunoprecipitation assays
using HeLa cells with anti-HIF1a or mock antibody treatment are consistent
with inhibition of HIF-1 binding to the VEGF HRE in the presence of
polyamide 1, and, to a more modest degree, 2. Concentrations of polyamides
are 1 mM.
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that targets the HRE while varying C-terminus tail moieties.
The C-terminus was chosen as the site of chemical variation
in our library, as subtle modifications to this area were previ-
ously found to influence nuclear localization of polyamide-
fluorophore conjugates (8,9). The polyamides generated in
this study retain high-binding affinity and specificity to the
target site. Synthesized as a control group was a library of
‘mismatch’ polyamides with identical C-terminus modifica-
tions but a different core targeted to the DNA sequence
50-WGGWCW-30, which is not found at the VEGF HRE.
The majority of polyamides from both libraries failed to
inhibit hypoxia-induced VEGF expression. We identified,
however, two non-fluorescent polyamides with biological
activity and binding affinities and specificities comparable
to those of polyamide-fluorescein conjugate 1.
MATERIALS AND METHODS
Synthesis of polyamides
Polyamides were synthesized by solid phase methods on Kaiser
oxime resin (Nova Biochem) except polyamide 3, which was
synthesized on Boc-b-alanine-PAM-resin (Peptides Interna-
tional) (19,20). Fluorescein-labeled polyamides 1–3 were
prepared as described previously (16). Polyamides 4–8 and
16–20 were cleaved from resin using the appropriate amine
and purified by reverse-phase HPLC. For the synthesis of
9–15 and 21–27, the polyamide was first cleaved with 3,
30-diamino-N-methyl-dipropylamine and purified by reverse-
phase HPLC. The designated acid was activated with PyBOP
(Nova Biochem) and coupled to the polyamide in dimethyl-
formamide and N,N-diisopropylethylamine to yield the final
product after reverse-phase HPLC purification. The purity
and identity of all polyamides were verified by analytical
HPLC and MALDI-TOF MS.
Confocal microscopy
Microscopy of live, unfixed cells was performed as described
previously (8,9). Briefly, cells were plated on glass-bottom
culture dishes for 24 h prior to overnight incubation with
2 mM polyamide. Imaging was performed on a Zeiss LSM
5 Pascal inverted laser scanning microscope.
Determination of DNA-binding affinities
and sequence specificities
Quantitative DNase I footprint titration experiments were
used to determine polyamide-binding affinities (Ka) to the 5
0-
ATACGT-30 sequence within the HRE of the VEGF promoter.
These experiments were performed using the 50-32P-labeled
197 bp PCR amplification product of the plasmid pGL2-
VEGF-Luc isolated by non-denaturing gel electrophoresis
(16,21). Quantitative DNase I footprint titration experiments
were conducted as reported previously (21).
Measurement of hypoxia-induced relative
VEGF mRNA
Cells were plated in 24-well plates at a density of 15–20 · 103
cells per well (30–40 · 103 cells/ml). Polyamides were
added to adhered cells in solutions of cell media at the
appropriate concentration and allowed to incubate with the
cells for 48 h. Then, hypoxic induction of gene expression
was chemically induced by adding deferoxamine (DFO) to
300 mM for an additional 16 h (22,23). Cells were har-
vested, RNA isolated, cDNA synthesized and quantitative
real-time RT–PCR conducted as described previously (16).
Briefly, RNA was isolated using the RNeasy kit (Qiagen),
cDNA synthesized using Powerscript (BD Biosciences)
and quantitative real-time RT–PCR performed using SYBR
Green PCR Master Mix (Applied Biosystems) on an ABI
7300 instrument. VEGF expression was measured relative
to b-glucuronidase (GUSB) as an endogenous control. Sta-
tistical analyses of results were determined using three inde-
pendent biological replicates. The primer sequences used for
VEGF and GUSB are available upon request. HeLa cells
were purchased from ATCC and U251 cells were received
as a gift from Dr Giovanni Melillo of the National Cancer
Institute.
Chromatin immunoprecipitation
Cells were plated on 15 cm diameter culture dishes and left to
attach overnight. Polyamides were incubated with the cells
for 48 h, and the cells were incubated for an additional
16 h after the addition of DFO to a final concentration of
300 mM. Cells were then treated with 1% formaldehyde for
10 min. Chromatin was isolated and sheared. HIF-1a anti-
bodies (Novus Biologicals) were used to immunoprecipitate
HIF-1 bound DNA fragments. After crosslink reversal,
PCRs using primers flanking the HRE of VEGF were used
to assess enrichment of bound fragments as compared to
mock-precipitated (no antibody) controls. PCRs were moni-
tored either using SYBR Green PCR Master Mix (Applied
Biosystems) on an ABI 7300 instrument, or directly visual-
ized using gel electrophoresis.
RESULTS
Confocal microscopy of polyamide-fluorophore
conjugates 1–3
Cellular uptake of polyamide-fluorescein conjugates 1–3
(Figure 1) was examined by confocal microscopy in live,
unfixed HeLa cells (Figure 2B). These data demonstrate
that polyamide-FITC conjugates 1 and 2, targeted to 50-
WTWCGW-30 and 50-WGGWCW-30, respectively, both
localize in the nucleus of HeLa cells. In contrast, polyamide
conjugate 3, also targeted to 50-WTWCGW-30 but with a
b-alanine residue at the C-terminus, is largely extracellular.
Suppression of hypoxia-inducible transcription in cell
culture by polyamide-fluorophore conjugates 1–3
Induction of VEGF mRNA by the hypoxia mimetic DFO in
the presence of polyamides 1–3 in HeLa cells was measured
by quantitative real-time RT–PCR (Figure 2C). Polyamide 1
inhibits the expression of DFO-induced VEGF mRNA pro-
duction by 50%. Polyamides 2 and 3 show diminished bio-
logical activity compared to 1. Together, the uptake and gene
expression data for 1–3 suggest that a polyamide targeted to
the HRE of VEGF must have efficient nuclear uptake in order
to inhibit hypoxia-induced expression of VEGF. Chromatin
immunoprecipitation experiments in cultured HeLa cells
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were performed to assess whether changes in VEGF promoter
occupancy by HIF-1a were consistent with displacement of
this protein by polyamide 1. Chromatin immunoprecipitation
assays with anti-HIF1a or mock antibody treatment are con-
sistent with inhibition of HIF-1 binding to the HRE in the
presence of polyamide 1 and polyamide 2 to a modest degree
(Figure 2D). In the absence of either polyamide 1 or 2, HIF-1
occupies the VEGF HRE following DFO-induction. HIF-1
occupancy at the VEGF HRE is reduced in cells treated
with 1 prior to DFO-induction. Polyamide 2 has a more lim-
ited effect.
Non-fluorescent HRE-targeted polyamides
We set out to synthesize a series of non-fluorescent HRE-
targeted polyamides (4–15) and their mismatch analogs
(16–27; Figure 3). Polyamides 4–15 can be considered in
three groups: 4–8 were designed with minimized tail motifs;
9–12 were designed to probe the functional groups present in
fluorescein dyes potentially responsible for the favorable
nuclear uptake profile of 1; and 13–15 were biotin conjugates.
Polyamides 4 and 5 were designed to have tail moieties
resembling the linker region of polyamide-fluorescein
conjugate 1. The dimethylaminopropylamine tail present in
5 is often placed at the C-terminus of polyamides used in
biophysical studies (1,2,24). Polyamide 6 was designed to
have a tail group of minimal size. Polyamides 7 and 8 have
2-morpholinoethanamine and 3-morpholinopropan-1-amine
tail groups, respectively. A four ring polyamide with a mor-
pholino tail was previously shown to have antibacterial activ-
ity in a mouse peritonitis model (25). The next group,
polyamides 9–12, was designed to reduce molecular weight
while retaining functional groups present in fluorescein and
maintaining the linker moiety found in polyamide 1. Polya-
mides 9–12 are derived from benzoic acid; 11 and 12 each
contain a carboxylic acid meta- to the attachment site, and
10 and 12 each have a hydroxyl group meta- to the attach-
ment site. Polyamides 13–15 are polyamide-biotin conju-
gates. The high affinity of the biotin moiety to streptavidin
may be useful for biochemical pull-down experiments. Poly-
amide 13 retains the linker found in 1–3 while 14 and 15 con-
tain 2- and 3-oxygen PEG linkers, respectively. Polyamides
16–27 were synthesized as mismatch control polyamides
for 4–15, respectively.
Binding affinities and specificities
Polyamides 4–15, designed to bind the 50-ATACGT-30 HRE-
binding site, share the same hairpin polyamide core as polya-
mides 1 and 3 but have different C-terminus tail groups. The
DNA-binding affinities of 4–15 for the HRE of VEGF were
measured by quantitative DNase I footprint titrations using a
50-32P-labeled PCR amplification product of the plasmid
pGL2-VEGF-Luc, which contains the VEGF HRE. Polyamide
conjugate 1 was previously found to have Ka ¼ 6.3 · 109 M1
at this site (16). Polyamides 4–15 were footprinted (Figure 4,
Supplementary Figure S1), and the Ka values obtained range
from 4.4 (±1.7) · 109 for 15 to 7.7 (±0.9) · 1010 for 4
(Table 1). With the exception of 15, the values obtained are
all higher than that measured for 1. Polyamides 4–15 retain
good specificity for the 50-ATACGT-30 HRE-binding site,
although a modest degree of non-specific binding is observed
at high concentrations for polyamides 4, 5, 7, 8 and 10.
Modifications to the tail moiety did not significantly abrogate
high-binding affinity and specificity.
Screening for suppression of hypoxia-inducible
transcription by polyamides 4–27 in HeLa cells
Induction of VEGF mRNA by the hypoxia mimetic DFO in
HeLa cells in the presence of polyamides 4–15 was measured
by quantitative real-time RT–PCR and compared to that of
polyamide 1 (Figure 5). Polyamides 5, 6 and 8 showed modest
inhibition of induced VEGF expression and polyamides 4 and
7 showed no difference relative to the untreated, induced con-
trol. Mismatch polyamides 16–19 showed no difference in
VEGF mRNA relative to the untreated, induced control. Poly-
amide 20 showed a modest effect (Supplementary Figure S2).
Polyamides 9 and 10 had a modest effect on induced
VEGF expression, whereas 11 and 12 inhibited induced
VEGF expression comparably to polyamide 1. Control poly-
amides 23 and 24 had a reduced effect as compared with their
match congeners 11 and 12 (Figure 6). HeLa cell growth was
not inhibited by 11, 12, 23 or 24 at 1 mM (Supplementary
Figure S3).
Figure 3. Structures of polyamides 4–27. Polyamides 4–15 target
50-WTWCGW-30 DNA sequences; 16–27 target 50-WGGWCW-30.
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Polyamides 13–15 had a modest effect on induced VEGF
expression. An appreciable difference between relative
VEGF mRNA levels was seen in cells treated with biotin con-
jugates 13 and 14 and their mismatch congeners 25 and 26
(Supplementary Figure 2C). It is noted that cells treated
with polyamides 25 and 26 had VEGF expression slightly
higher than that of the untreated, induced control.
Suppression of hypoxia-inducible transcription
by polyamides in U251 cells
The effects of HRE targeted polyamides 1 and 11 and control
polyamides 2 and 23 were tested in U251 cells, which express
a higher level of VEGF than HeLa cells (Figure 7). Uptake
of optically tagged polyamides 1 and 2 was examined by
confocal microscopy in live, unfixed U251 cells dosed with
2 mM of 1 or 2 (Figure 7A). Induction of VEGF mRNA in
the presence of polyamides 1 and 11 was inhibited dose
dependently (Figure 7B). Polyamide 2 had minimal effect
on VEGF expression at 0.2 mM. However, at 1 mM, polya-
mide 2 had a moderate effect, though still less than that of
its match congener 1. Polyamide 23 had a more modest effect
than its match congener 11 at both 0.2 and 1 mM. We also
undertook chromatin immunoprecipitation experiments in
U251 cells to assess changes in VEGF promoter occupancy
by HIF-1a in the presence of 1, 2, 11 and 23 (Figure 7C).
Chromatin immunoprecipitation assays with anti-HIF1a or
mock antibody treatment are consistent with decreased occu-
pancy of HIF-1a at the VEGF HRE in the presence of poly-
amides 1 and 11 at 1 mM. Polyamide 23 has a more modest
effect compared with that of its match congener 11. At the
concentration tested (1 mM), polyamide 2 has an effect statis-
tically similar, though slightly less than that of 1. This is not
unexpected; 2 also showed some inhibition of VEGF mRNA
Figure 4. Plasmid sequence and DNA-binding properties of polyamides
11 and 12. (A) Illustration of plasmid pGL2-VEGF-Luc. The HRE match
binding site M is indicated by the box. (B and C) Quantitative DNase
I footprint titration experiments for polyamides 11 (B) and 12 (C) on the
197 bp, 50-end-labeled PCR product of plasmid pGL2-VEGF-Luc: lanes
1–11, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM,
3 pM and 1 pM polyamide, respectively; lane 12, DNase I standard; lane 13,
intact DNA; lane 14, A reaction; lane 15, G reaction. Each footprinting gel is
accompanied by a binding isotherm for polyamides binding the match site M
(below).
Figure 5. Induction of VEGF mRNA by the hypoxia mimetic deferoxamine
(DFO) in the presence of polyamides 1 and 4–15 measured by quantitative
real-time PCR. Concentrations of polyamides are 1 mM.
Table 1. Binding affinities (M1) for polyamides 4–15
Polyamide 50-TACGTG-30
4 7.7 (±0.9) · 1010
5 6.2 (±1.2) · 1010
6 2.5 (±0.3) · 1010
7 4.0 (±0.9) · 1010
8 3.8 (±0.5) · 1010
9 1.5 (±0.6) · 1010
10 2.1 (±0.4) · 1010
11 2.6 (±0.4) · 1010
12 1.1 (±0.2) · 1010
13 7.2 (±1.1) · 109
14 4.8 (±1.9) · 109
15 4.4 (±1.7) · 109
Equilibrium association constants reported are mean values from three DNase I
footprint titration experiments; standard deviations are shown in parentheses.
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at this concentration. PCR amplification at an irrelevant locus
in the coding region of GUSB showed minimal enrichment
(1- to 1.5-fold over background) for polyamide-treated
and control samples (data not shown).
DISCUSSION
Previous studies on fluorophore-labeled polyamides have
revealed several parameters that affect cellular trafficking
of these molecules, including number of heterocyclic ring
pairs, relative Py/Im content and sequence, and choice of
fluorophore and attachment site (8,9). Among fluorophores
considered, the protonation state of fluorescein is pH sensi-
tive, while those of tetramethylrhodamine and Bodipy are
not. In previous work, nuclear localization of polyamide
2 in HeLa cells was ablated when the cells were grown in
glucose- and sodium pyruvate-free media, but subsequently
restored when normal growth media were added (8). This
suggests that for some polyamides, nuclear localization is
energy dependent. Many fluorophore-polyamide conjugates
that exhibit a punctate, cytoplasmic staining pattern co-
localize with LysoTracker, a lysosomal stain. Verapamil, a
calcium channel and P-glycoprotein efflux pump inhibitor,
was shown to facilitate nuclear uptake of a Bodipy-polyamide
conjugate otherwise sequestered within cytoplasmic vesicles
(7). Some polyamides with minimal nuclear localization,
e.g. 3, localize mostly in the extracellular space. Neverthe-
less, the fact that many eight-ring hairpin polyamide-
fluorophore conjugates do localize in the nuclei of live cells
is encouraging.
The inhibition of induced VEGF expression in the presence
of polyamide 1, which binds the VEGF HRE, is an important
proof-of-principle experiment for the use of designed DNA-
binding ligands to modulate the expression of specific sets
of genes. Moving ahead, anticipated experiments include
studies in mammalian model systems to account for biodistri-
bution, availability and metabolism of polyamides. Toward
this end, we have attempted to identify polyamides capable
of nuclear localization but of simpler structures and lower
molecular weights than dye conjugates. The inhibition of
Figure 6. Induction of VEGF mRNA by the hypoxia mimetic deferoxamine
(DFO) in the presence of polyamides 11, 12, 23 and 24 measured by
quantitative real-time PCR. Polyamides 11 and 12, which bind the
50-ATACGT-30 sequence found in the VEGF HRE, show inhibition of
DFO-induced VEGF expression. Polyamides 23 and 24, which target
50-WGGWCW-30, have a more modest effect. Concentrations of polyamides
are 0.2 and 1 mM.
Figure 7. (A) Uptake of polyamides 1 (left) and 2 (right) in U251 cells.
(B) Induction of VEGF mRNA by the hypoxia mimetic deferoxamine (DFO)
in the presence of polyamides 1, 2, 11 and 23 in U251 cells measured by
quantitative real-time PCR. Concentrations of polyamides are 0.2 and 1 mM.
(C) Chromatin immunoprecipitation assays with anti-HIF1a or mock
antibody treatment expressed as fold-enrichment (specific/mock) of a 120 bp
sequence at the VEGF HRE measured by real-time PCR. Concentrations of
polyamides are 1 mM.
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induced VEGF expression with HRE-targeted polyamide 1,
but not 2, which targets a different DNA sequence or 3,
which exhibits considerably less nuclear localization, demon-
strates the viability of VEGF inhibition as a proxy for nuclear
localization of polyamides that bind the HRE.
The ability to interrogate polyamide cellular uptake and
nuclear localization by affecting expression of an endogenous
inducible gene enables exploration of the nuclear uptake
profiles of non-fluorescent tail moieties. The quantitative real-
time RT–PCR data presented show that removal of the
fluorescein dye (polyamide 4) and step-wise ablation of the
linker moiety (polyamides 5 and 6) diminish the biological
activity of these compounds as compared with polyamide 1
in this system. The Ka values measured for 4–6 are between
4- and 12-fold higher than that measured for the parent poly-
amide 1 on the same DNA sequence. Similarly, the binding
affinities of N-alkylaminemorpholino tail polyamides 7 and
8 are 6-fold higher than that of the parent polyamide 1
for the same binding site, but only modest biological activit-
ies are observed.
Data generated from cultured HeLa cells treated with poly-
amides 9–12 were more encouraging. These compounds were
designed to probe contributions of the alcohol and carboxylic
acid groups of fluorescein to the cellular uptake and nuclear
localization observed for 1. This was done by synthesizing a
focused series of polyamides composed of an amide-bond
linked benzene ring containing four possible permutations
of alcohol and/or carboxylic acid substituents at the meta-
positions. Polyamides 9–12 demonstrated good sequence
specificities and binding affinities greater than that of 1. Poly-
amide conjugates of benzoic acid and 3-hydroxy benzoic
acid, 9 and 10, respectively, show a modest degree of biologi-
cal activity, but those conjugated to either isophthalic acid or
5-hydroxy isophthalic acid, 11 and 12, respectively, demon-
strate a biological effect similar to that observed for the
parent polyamide 1. These results suggest that the presence
of the carboxylic acid group on the benzene ring is a positive
determinant of nuclear localization in this system.
Biotin conjugates 13–15 differ in the identity of the linker
moiety and were of interest due to the potential utility of
these conjugates for pull-down experiments. The binding
affinities measured by quantitative DNase I footprint titration
experiments for these conjugates were similar to that of the
parent polyamide 1. By quantitative real-time RT–PCR, poly-
amides 13–15 all demonstrated modest biological activities
and the results do not suggest strong differences in activities
based on linker identity. The modest activities of the biotin
conjugates, which might reflect a moderate degree of nuclear
uptake, are neither encouraging nor dismissive of potential
applications of these conjugates.
Our working hypothesis regarding VEGF inhibition by poly-
amides is through direct interactions with the DNA–HIF-1
interface at the HRE that prevents HIF-1 binding, most likely
by an allosteric mechanism. To explore this model further, we
used chromatin immunoprecipitation to assess HIF-1 occu-
pancy at the VEGF HRE under hypoxia-induced conditions
in HeLa cells in the presence and absence of match (and mis-
match) polyamides with variable C-terminus tails. Antibodies
against HIF-1a were found to enrich fragments of DNA con-
taining the VEGF HRE after DFO-induction. This enrichment
was reduced in samples treated with polyamide 1 and, to a
lesser extent, polyamide 2. We also undertook experiments
in U251 cells, which express VEGF more robustly and have
previously been used as a model cell line for studying hypoxia-
induced VEGF expression (17).
Polyamide-fluorescein conjugates 1 and 2 localize in the
nucleus of U251 cells. Induction of VEGF mRNA in the pres-
ence of polyamides 1, 2, 11 and 23 at 0.2 and 1 mM in U251
cells was measured by quantitative real-time RT–PCR. Poly-
amide 1 showed significant inhibition at both concentrations.
Interestingly, at 1 mM polyamide 2 showed inhibition greater
than that measured in HeLa cells but still significantly less
than 1. Polyamide 11 exhibits dose-dependent inhibition of
VEGF similar to that measured in HeLa cells, while 23
showed modest activity at both concentrations comparable
to that measured in HeLa cells. Chromatin immunoprecipita-
tion of HIF-1a from U251 cells treated with HRE-targeted
polyamides 1 and 11 and mismatch polyamides 2 and 23
shows that enrichment of HIF-1a bound DNA fragments
containing the VEGF HRE after DFO induction is inhibited
by pre-treatment with polyamides 1 and 11, and to a lesser
extent 2 and 23. This is generally consistent with a mecha-
nism whereby polyamides 1 and 11 exert their effect by
preventing HIF-1 binding to the cognate HRE. This is also
consistent with DNase I footprint titrations and gel shift
assays in vitro (16).
This report identifies two polyamides, 11 and 12, with non-
fluorescent moieties at the C-terminus that bind the VEGF
HRE that have biological activity similar to that of the
fluorescein-polyamide conjugate 1 known to localize in the
nucleus. Both polyamides retain an amide-linked benzene
ring with a carboxylic acid meta- to the attachment point
and are similar in structure to the proximal portion of fluores-
cein. Work is ongoing to synthesize a second series of poly-
amides designed to examine the role of the aromatic ring and
the carboxylic acid functional group in aiding nuclear local-
ization. As the mechanism of polyamide uptake and nuclear
localization continues to be elucidated, it is currently unclear
whether the biological activity of 11 and 12 is due to
improved ability to buffer the wide range of pH values that
may be encountered in the cell (e.g. lysosomes), improved
nuclear localization resulting in an increased effective polya-
mide concentration at the DNA, or decreased efflux of
polyamide from the cell perhaps through one or several
ATP-dependent drug efflux pumps (26,27).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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